The U.S. Food and Drug Administration has cleared the way for the first trial to see if human embryonic stem cells can treat people safely, Reuters reports. Geron Corp, a California biotechnology company, said it plans a clinical trial to try to use the stem cells to re-grow nerve tissue in patients with crushed, but [Sign in to read the full article...]